Disparities in selective referral for cancer surgeries: implications for the current healthcare delivery system by Sun, Maxine et al.
 Disparities in selective referral for cancer surgeries: implications
for the current healthcare delivery system
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Sun, Maxine, Pierre I Karakiewicz, Jesse D Sammon, Shyam
Sukumar, Mai-Kim Gervais, Paul L Nguyen, Toni K Choueiri,
Mani Menon, and Quoc-Dien Trinh. 2014. “Disparities in
selective referral for cancer surgeries: implications for the
current healthcare delivery system.” BMJ Open 4 (3): e003921.
doi:10.1136/bmjopen-2013-003921.
http://dx.doi.org/10.1136/bmjopen-2013-003921.
Published Version doi:10.1136/bmjopen-2013-003921
Accessed February 19, 2015 3:44:47 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12064490
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAA
Disparities in selective referral for cancer
surgeries: implications for the current
healthcare delivery system
Maxine Sun,1 Pierre I Karakiewicz,1 Jesse D Sammon,2 Shyam Sukumar,2
Mai-Kim Gervais,3 Paul L Nguyen,4 Toni K Choueiri,5 Mani Menon,2
Quoc-Dien Trinh6
To cite: Sun M,
Karakiewicz PI, Sammon JD,
et al. Disparities in selective
referral for cancer surgeries:
implications for the current
healthcare delivery system.
BMJ Open 2014;4:e003921.
doi:10.1136/bmjopen-2013-
003921
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2013-003921).
MS and PIK contributed
equally.
Received 1 September 2013
Revised 16 January 2014
Accepted 21 January 2014
For numbered affiliations see
end of article.
Correspondence to
Dr Maxine Sun;
mcw.sun@umontreal.ca
ABSTRACT
Objectives: Among considerable efforts to improve
quality of surgical care, expedited measures such as a
selective referral to high-volume institutions have been
advocated. Our objective was to examine whether
racial, insurance and/or socioeconomic disparities exist
in the use of high-volume hospitals for complex
surgical oncological procedures within the USA.
Design, setting and participants: Patients
undergoing colectomy, cystectomy, oesophagectomy,
gastrectomy, hysterectomy, lung resection,
pancreatectomy or prostatectomy were identified
retrospectively, using the Nationwide Inpatient Sample,
between years 1999 and 2009. This resulted in a
weighted estimate of 2 508 916 patients.
Primary outcome measures: Distribution of
patients according to race, insurance and income
characteristics was examined according to low-volume
and high-volume hospitals (highest 20% of patients
according to the procedure-specific mean annual
volume). Generalised linear regression models for
prediction of access to high-volume hospitals were
performed.
Results: Insurance providers and county income levels
varied differently according to patients’ race. Most
Caucasians resided in wealthier counties, regardless of
insurance types (private/Medicare), while most African
Americans resided in less wealthy counties (≤$24 999),
despite being privately insured. In general, Caucasians,
privately insured, and those residing in wealthier
counties (≥$45 000) were more likely to receive surgery
at high-volume hospitals, even after adjustment for all
other patient-specific characteristics. Depending on the
procedure, some disparities were more prominent, but
the overall trend suggests a collinear effect for race,
insurance type and county income levels.
Conclusions: Prevailing disparities exist according to
several patient and sociodemographic characteristics for
utilisation of high-volume hospitals. Efforts should be
made to directly reduce such disparities and ensure
equal healthcare delivery.
INTRODUCTION
There is empirical evidence suggesting that
hospital volume represents an established
proxy for better quality of care after complex
surgical oncological procedures.1–7 In conse-
quence, amid many efforts to improve
quality of surgical care, expedited measures
such as a selective referral to high-volume
institutions have been advocated.8–10
In this instance, there has been a remark-
able progress in the reduction of adverse out-
comes following a major surgical oncological
procedure, which includes decreasing cancer
death rates in the USA over the past two
decades.11 Nonetheless, improvements are
not consistent across all population
strata.12 13 For example, reduction in cancer
deaths in persons with low socioeconomic
status and in African Americans remains
slow. Such lack of improvement in selected
segments of the US population may suggest
underlying disparities,12 14 among them
access to care.15 Consequently, eliminating
such disparities across various levels of socio-
demographic factors represents an over-
reaching objective of several initiatives that
have been implemented by several organisa-
tions—among them, the American Cancer
Society16 and the US Department of Health
and Human Services Health People
initiative.17
In the context of such extensive collabora-
tive efforts, further data are needed to better
describe the disparities in the regionalisation
process. The current study seeks to assess
speciﬁc sociodemographic characteristics
Strengths and limitations of this study
▪ The study examined eight major surgical onco-
logical procedures.
▪ The study relied on a large population-based
cohort representative of the USA.
▪ No additional information on disease character-
istics was available, possibly confounding the
observed effect.
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and utilisation of high-volume hospitals across major sur-
gical oncological procedures performed in the USA
during the last decade. Our hypothesis states that some
sociodemographic characteristics are consistently asso-
ciated with inferior access to high-volume hospital care.
MATERIALS AND METHODS
Data source
Relying on the Nationwide Inpatient Sample (NIS), hos-
pital discharges in the USA between 1 January 1999 and
30 December 2009 were abstracted. The NIS is a set of
longitudinal hospital inpatient databases included in the
Healthcare Cost and Utilization Project family, created
by the Agency for Healthcare Research and Quality
through a Federal-state partnership.18 The database
includes discharge abstracts from eight million hospital
stays and incorporates patient and hospital information,
including patients covered by Medicare, Medicaid,
private insurance and other insurance types.
Each discharge includes up to 15 inpatient diagnoses
and procedures per hospitalisation. All procedures and
diagnoses are coded using the International Classiﬁcation
of Disease, 9th revision, Clinical Modiﬁcation (ICD-9-CM).
Included patient and sociodemographic characteristics
are patient sex, race, age, expected source of payment,
ZIP code of residence, outcomes (intraoperative and
postoperative complications during hospitalisation,
in-hospital mortality), as well as hospital information
(unique hospital identiﬁer, hospital location). Patients’
socioeconomic status is also available using a proxy
income, deﬁned by county-speciﬁc ZIP code according
to the US census.
Study cohort
A total of eight major surgical oncological procedures
were selected for evaluation of the volume-disparity rela-
tionship: colectomy, cystectomy, oesophagectomy, gastrec-
tomy, hysterectomy, pneumonectomy, pancreatectomy
and prostatectomy. Analyses were restricted to cancer
diagnoses only. Relying on speciﬁc ICD-9-CM procedure
codes (available on request), each surgical procedure was
assessed independently.
Primary outcome
The primary dependent variable of interest was hospital
volume, classiﬁed as high-volume, medium-volume and
low-volume hospitals. Hospital volume was deﬁned
according to previously described methodology.19
Speciﬁcally, hospital volume for each given surgical
oncological procedure was determined according to its
mean annual procedural volume, namely the number of
procedures performed overall divided by the number of
years the hospital performed the operation, for the
entire study period (1999–2009). Such measure compen-
sates for the ﬂuctuation of varying hospital volume over-
time, and represents an aggregation of overall
procedure-speciﬁc experience for the entire study span
of analysis. Subsequently, hospital volume was cate-
gorised into three groups using patient quintiles, where
high-volume hospitals were formed by patients within
the ﬁrst 20% of patients according to mean annual
volume, medium-volume hospitals were formed by
patients within the middle 60%, and low-volume hospi-
tals represented the lowest 20% of patients. It is note-
worthy that hospital volume was also examined as a
continuous variable for methodological stringency.
However, categorisation of hospital volume into groups
was deemed as more optimal for the purpose of clinical
interpretation.
Patient and hospital characteristics
Available independent variables for analyses included
patient age at hospitalisation, race, sex, insurance status,
baseline comorbidities, patient ZIP code income, as well
as hospital location. Information on race was categorised
as Caucasian, African American, Hispanic, other (Asian
or Paciﬁc Islander, Native American) or unknown. Given
that approximately 25% of patients were of unknown
race, we chose not to exclude these patients from the
entire cohort so as not to induce any bias. That said,
stratiﬁed bivariate analyses omitted its consideration as it
would be difﬁcult to interpret and properly comment
on patients with missing race information. Insurance
status was classiﬁed based on the expected primary
payer, and included Medicare, Medicaid, private insur-
ance (Blue Cross, commercial carriers, private HMOs
and PPOs) and other insurance types including those
who were uninsured. Patient age was considered as a
continuous variable. Baseline comorbidities were deter-
mined using a Charlson comorbidity index-derived
score,20 adapted by Deyo et al,21 and assessed as a con-
tinuous variable.
Income at the patient level was not available within
the NIS. In consequence, we relied on the median
household income of the patient’s ZIP code of resi-
dence, which was derived from the US census. Four cat-
egories were available within the database1: <$25 000,2
$25 000–$34 999,3 $35 000–$44 999 and4 ≥$45 000.
Statistical analyses
In order to make national estimates of the number of
discharges more accurate, the crude distribution was
weighted according to the provided NIS population
weights. All subsequent analyses were performed on the
weighted population.
Baseline descriptives were generated for sex, race,
insurance status and income stratiﬁed according to hos-
pital volume categories. Univariable analysis was com-
puted whenever appropriate using χ2 and independent
sample t tests for categorical and continuous variables,
respectively. Generalised linear regression models were
used to examine the impact of the primary predictors
(race, insurance status, income) on access to high-
volume hospital. Adjustment was made for patient age
and baseline comorbidities. Year of surgery was
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modelled as a random effect. In contrast, adjustment for
clustering of hospitals was not made given that hospitals
represented the dependent variable of interest. The
odds of receiving care at high-volume hospitals were cal-
culated. All tests were two-sided with statistical signiﬁ-
cance set at p<0.05. Analyses were conducted using the
R statistical package (the R foundation for Statistical
Computing, V.2.15.0).
RESULTS
Baseline descriptives
A weighted estimate of 2 508 916 patients underwent
one of the eight examined procedures. Baseline sociode-
mographic characteristics in the entire cohort are
described in table 1. Mean age was 66 years (median
66). Sociodemographic characteristics differed accord-
ing to procedure type. For example, patients in the pros-
tatectomy group were youngest (median 62) and those
in the colectomy group were oldest (median 72). Across
nearly all surgeries, the majority of patients were
Caucasian and ranged from 48% to 67% for gastrectomy
and cystectomy, respectively. With respect to insurance
status, privately insured patients ranged from 29% to
64% for colectomy and prostatectomy, respectively.
Patients with Medicare insurance ranged from 30% to
64% for prostatectomy and colectomy, respectively. The
proportion of patients with the highest ZIP code income
(≥$45 000) ranged between 30% and 38% for colectomy
and prostatectomy, respectively.
Subsequently, patients’ race, insurance status and
income levels were assessed in the entire cohort (table 2).
Among Caucasians, most patients had high income
(≥$45 000), regardless of being privately insured (42%) or
having Medicare coverage (32%). Similar trends were
recorded among Hispanics and persons of other races. In
contrast, among African Americans, despite being pri-
vately insured, the majority of patients had low income
(≤$24 000: 27%). These associations were subsequently
conﬁrmed within each procedure (data not shown).
Bivariate associations for hospital volume
Table 3 shows overall descriptions of race, insurance
types and income levels stratiﬁed according to low-
hospital and high-hospital volume. For all procedure
types, patients’ sociodemographic factors differed signiﬁ-
cantly according to hospital volume (all p≤0.01), where
Caucasian, private insurance and high-income patients
were more likely to be treated at high volume, while
African American/Hispanic, Medicare/Medicaid, and
low-income patients were more likely to be treated at
low-volume hospitals. The lowest and highest propor-
tions of individuals of Caucasian race who were treated
at high-volume hospitals were recorded for gastrectomy
(50%) and oesophagectomy/lung resections (both
73%), respectively. With respect to patients with private
insurance, the lowest and highest proportions of indivi-
duals treated at high-volume hospitals were observed for
colectomy (34%) and prostatectomy (71%), respectively.
The lowest and highest proportions of patients with a
median ZIP code income of ≥$45 000 treated at high-
volume hospitals were recorded for cystectomy (28%)
and prostatectomy (46%), respectively.
Insurance and hospital volume according to race
Subsequently, a more detailed stratiﬁcation was per-
formed. Speciﬁcally, we examined the relationship
between hospital volume and insurance status for each
race group (table 4). Most importantly, regardless of
race, those privately insured were more frequently
treated at high-volume than low-volume hospitals in the
settings of colectomy, cystectomy, lung resections, pan-
createctomy and prostatectomy. In contrast, Medicare
patients were more frequently treated at low-volume hos-
pitals. However, this observation did not apply to oeso-
phagectomies performed on African Americans and
Hispanics. In these groups, Medicare beneﬁciaries were
more frequently treated at high-volume than low-volume
hospitals (African Americans: 49% vs 37%, Hispanics:
55% vs 41%), while privately insured patients were more
frequently treated at low-volume than high-volume hos-
pitals (African Americans: 32% vs 26%, Hispanics: 36%
vs 24%, all p<0.001). For hysterectomy, African
Americans with Medicare coverage were more frequently
treated at high-volume than low-volume hospitals (48%
vs 44%, p<0.001).
Income and hospital volume according to race
A second more detailed stratiﬁcation was performed in
order to examine the relationship between hospital
volume and ZIP code income for each race group (table
5). Most importantly, regardless of race, patients with
the highest income (≥$45 000) were more frequently
treated at high-volume hospitals for colectomy, gastrec-
tomy, hysterectomy and prostatectomy. This relationship
did not apply to cystectomy, oesophagectomy and pan-
createctomy. Speciﬁcally, the proportions of Caucasians
with high income treated at low-volume and high-
volume hospitals were similar (33% vs 30%). Moreover,
most oesophagectomies were performed on African
Americans who had low income (<$25 000) and were
treated in high-volume hospitals (87%). Among African
Americans treated with pancreatectomy, the majority
had low income (<$25 000).
Generalised linear regression models
Figure 1A illustrates the multivariable effect of race for
prediction of high-volume hospital utilisation. For seven
of the eight procedures (cystectomy, oesophagectomy,
gastrectomy, hysterectomy, lung resection, pancreatec-
tomy and prostatectomy), African Americans and/or
Hispanics predisposed to lower rates of treatment at
high-volume hospitals relative to their Caucasian race
counterparts (OR 0.21–0.93). Figure 1B illustrates the
multivariable effect of insurance status. For six of the
eight procedures (colectomy, cystectomy, gastrectomy,
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Table 1 Baseline descriptive characteristics according to eight major surgical oncological procedures*
Variables Total Colectomy Cystectomy Oesophagectomy Gastrectomy Hysterectomy Lung Pancreatectomy RP
Number of patients (%) 100 37 3.2 0.7 3.3 9.8 14.6 2.3 29.1
Hospital volume
Mean (median) — 46 (39) 19 (8) 7 (4) 9 (5) 32 (23) 42 (29) 19 (10) 117 (64)
IQR 22–62 4–22 2–11 3–10 10–48 15–51 4–23 28–137
Age (years)
Mean (median) 66 (66) 70 (72) 68 (70) 64 (64) 67 (69) 63 (62) 67 (68) 65 (66) 62 (62)
IQR 58–74 62–80 62–76 56–71 58–77 54–72 60–74 57–74 56–67
Female (%) 40 53 18 20 39 100 49 50 0
Race (%)
Caucasian 61 60 67 64 48 61 66 61 60
African American 7 8 4 5 10 5 5 7 8
Hispanic 4 4 3 3 10 4 2 6 4
Others 4 4 3 3 10 4 3 5 3
Unknown 25 25 25 26 21 26 24 23 25
Insurance status (%)
Private 42 29 31 46 32 49 34 40 64
Medicaid 3 3 4 6 7 4 4 5 2
Medicare 51 64 62 44 56 42 59 50 30
Others 4 4 4 4 5 5 4 5 4
Median income (%)
<$25 000 15 17 15 16 18 12 16 16 12
$25 000–$34 999 24 26 25 24 24 22 24 23 21
$35 000–$44 999 26 26 27 26 24 26 26 25 26
≥$45 000 34 30 32 32 32 37 32 34 38
Unknown 2 2 2 2 2 2 2 3 3
*Rates are weighted according to the NIS-assigned discharge weights.
NIS, Nationwide Inpatient Sample; RP, radical prostatectomy.
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hysterectomy, lung resection and prostatectomy),
Medicare, Medicaid and/or other insurance types were
less likely to be treated at high-volume hospitals com-
pared to privately insured individuals (OR 0.52–0.87).
Finally, in ﬁgure 1C, the multivariable effect of ZIP code
income is shown. For six of the eight procedures (colec-
tomy, oesophagectomy, gastrectomy, hysterectomy, lung
resection and prostatectomy), high income (≥$45 000)
was associated with a higher rate of high-volume hospi-
tals utilisation relative to their lowest income counter-
parts (OR 1.32–1.92).
DISCUSSION
The importance of the volume–outcome relationship or,
more precisely, whether higher volume institutions are
independently associated with worse outcomes has been
intricately debated in the past two decades.3–5 22–27 At
present, most would agree that procedural volume at
least represents a proxy for better quality of care follow-
ing a major procedure.1–7 9 This has led to payer-led
initiatives, such as the Leapfrog Group for Patient
Safety,8 10 advocating the utilisation of high-volume insti-
tutions on a national level. Following the implementa-
tion of such programmes, some studies have noted a
discrepancy in the utilisation of high-volume hospitals
across various sociodemographic populations.15 19 For
example, previous studies showed that persons of
African American race were less likely to receive care at
a high-volume hospital than their Caucasian race coun-
terparts.15 19 Disparities have also been observed accord-
ing to a patient’s insurance status, where most studies
alluded to difﬁculties in accessing high-volume hospitals
among patients with Medicaid/Medicare insurance
types.15 In addition, disparities have consistently been
reported for persons with poverty.15 28 29
Theoretically, equal access to care for all segments of
the population with regard to cancer prevention, early
detection and treatment can signiﬁcantly reduce dispar-
ities in cancer care, and ultimately reduce the incidence
of adverse outcomes during hospitalisation. In order to
achieve this target, more research is needed to better
specify public health interventions. As such, the purpose
of the current study was to examine whether disparities
with respect to race, insurance and income levels exist
for receipt of care at high-volume institutions across
eight major oncological procedures.
Our hypothesis stated that disparities pertaining to
race, insurance status and income levels may exist with
respect to utilisation of high-volume hospitals.
Speciﬁcally, we postulated that African Americans/
Hispanics, non-privately insured individuals and low-
income level patients are less likely to be treated at high-
volume hospitals. Our bivariate analyses conﬁrmed this
hypothesis. Moreover, our multivariable analysis further
corroborated this suspicion. Indeed, African Americans/
Hispanics and non-privately insured patients had lower
rates of high-volume hospital utilisation in 7/8 and 6/8
procedures, respectively. In contrast, patients residing in
high-income neighbourhoods were more likely to be
treated at high-volume hospitals in 6/8 procedures.
Taken together, our data convincingly demonstrate
that African Americans/Hispanics, non-privately insured
and low-income individuals were signiﬁcantly more likely
to be treated at low-volume hospitals. This occurred in
the majority of the examined scenarios. This implies
that racial, insurance and income-related disparities
affect access to treatment at high-volume hospitals.
Limited access to treatment at high-volume hospitals is
Table 2 Bivariate associations between insurance types and income, stratified according to race*
Income groups
Race Insurance status <$25 000 $25 000–$34 999 $35 000–$44 999 ≥$45 000
Caucasian Private 9.5 20.5 26.2 41.7
Medicaid 23.9 30.3 24.1 19.1
Medicare 13.4 25.6 26.8 32.2
Other 16.5 29.0 25.8 24.5
African American Private 27.2 23.9 23.0 23.6
Medicaid 46.9 23.6 15.2 10.7
Medicare 38.5 26.2 18.7 14.6
Other 36.4 25.6 18.6 14.4
Hispanic Private 20.4 21.5 25.0 29.2
Medicaid 38.5 25.0 22.3 12.1
Medicare 28.4 23.7 23.1 22.0
Other 30.6 21.0 22.0 18.5
Others Private 8.6 15.5 23.0 50.9
Medicaid 16.9 20.5 23.1 32.9
Medicare 14.4 20.4 24.8 38.5
Other 15.2 19.8 23.1 31.3
All p<0.001.
*Percentages may not sum up to 100% because unknown income, insurance and race are not displayed within the table.
Sun M, Karakiewicz PI, Sammon JD, et al. BMJ Open 2014;4:e003921. doi:10.1136/bmjopen-2013-003921 5
Open Access
Table 3 Weighted proportions (%) of race, insurance
status and median income stratified according to
procedure-specific low-hospital and high-hospital volume*
Low
volume
High
volume p Value
Colectomy
Race <0.001
Caucasian 58.8 62.7
African American 6.7 7.8
Hispanic 5.0 4.2
Others 3.6 4.0
Insurance status <0.001
Private 23.6 33.5
Medicaid 4.4 2.6
Medicare 66.4 61.4
Others 5.6 2.5
Median income <0.001
<$25 000 22.7 13.4
$25 000–$34 999 34.3 19.5
$35 000–$44 999 24.4 24.5
≥$45 000 15.9 40.8
Cystectomy
Race <0.001
Caucasian 64.5 69.6
African American 3.9 2.6
Hispanic 3.4 3.7
Others 2.9 3.8
Insurance status <0.001
Private 26.9 35.6
Medicaid 4.3 3.3
Medicare 64.8 56.5
Others 4.0 4.6
Median income <0.001
<$25 000 13.6 17.7
$25 000–$34 999 26.5 27.9
$35 000–$44 999 27.8 24.3
≥$45 000 29.8 28.0
Oesophagectomy
Race <0.001
Caucasian 56.5 72.2
African American 8.4 1.1
Hispanic 3.8 4.5
Others 4.2 3.0
Insurance status 0.010
Private 42.8 47.9
Medicaid 8.3 4.2
Medicare 43.5 44.7
Others 5.5 3.2
Median income 0.032
<$25 000 18.3 14.2
$25 000–$34 999 25.3 23.2
$35 000–$44 999 26.6 27.0
≥$45 000 28.5 31.9
Gastrectomy
Race <0.001
Caucasian 46.8 50.2
African American 11.7 9.3
Hispanic 9.5 9.5
Others 5.8 15.3
Continued
Table 3 Continued
Low
volume
High
volume p Value
Insurance status <0.001
Private 25.3 38.8
Medicaid 6.4 8.1
Medicare 62.4 47.6
Others 5.8 5.4
Median income <0.001
<$25 000 20.3 18.7
$25 000–$34 999 30.7 19.0
$35 000–$44 999 25.4 19.6
≥$45 000 21.4 40.5
Hysterectomy
Race <0.001
Caucasian 59.6 63.7
African American 4.4 4.4
Hispanic 4.8 2.2
Others 3.7 3.4
Insurance status <0.001
Private 44.2 54.2
Medicaid 5.1 3.8
Medicare 44.4 38.6
Others 6.3 3.4
Median income <0.001
<$25 000 15.0 10.9
$25 000–$34 999 30.5 18.3
$35 000–$44 999 26.8 25.7
≥$45 000 25.4 43.5
Lung resection
Race <0.001
Caucasian 60.9 72.7
African American 6.6 4.2
Hispanic 3.8 1.6
Others 3.7 2.7
Insurance status <0.001
Private 30.7 38.0
Medicaid 5.7 3.6
Medicare 58.9 55.5
Others 4.7 2.9
Median income <0.001
<$25 000 16.6 15.6
$25 000–$34 999 27.9 21.1
$35 000–$44 999 25.7 23.0
≥$45 000 27.7 38.0
Pancreatectomy
Race <0.001
Caucasian 56.0 65.6
African American 8.4 4.1
Hispanic 6.1 5.4
Others 4.5 2.7
Insurance status <0.001
Private 36.2 42.4
Medicaid 5.8 4.2
Medicare 52.9 49.1
Others 5.1 4.3
Median income <0.001
<$25 000 15.3 17.7
Continued
6 Sun M, Karakiewicz PI, Sammon JD, et al. BMJ Open 2014;4:e003921. doi:10.1136/bmjopen-2013-003921
Open Access
ultimately linked to limited access to academic centres,
hospitals located in the urban setting, hospitals with
better bed-size capacity and increased market concentra-
tion, since high-volume hospitals are often characterised
with such features.23 30 Such patterns of care have been
shown to result in suboptimal outcomes according to
the practice-makes-perfect hypothesis. Therefore, these
access-related disparities should be addressed to ensure
optimal outcomes.
It is also noteworthy that the observed disparities
often reﬂected overlapping and embedded effects of the
examined sociodemographic characteristics, and varied
according to procedures. For example, patients with
private insurance often lived in ZIP code areas with
higher income. However, this was only true for
Caucasians. In African Americans, despite being pri-
vately insured, most patients lived in areas with the
lowest income (<$25 000). Similarly, most Caucasian
patients with Medicare insurance had high income,
while most African American patients with Medicare
insurance had low income. Hence, racial, insurance or
income disparities are not separate singular effects, but
a weaving of all such denominators, which ultimately
come to inﬂuence access to care. Indeed, the causes of
disparities in cancer care across different sociodemo-
graphic groups are complex, and often represent inter-
related social, economic, cultural and healthcare system
factors. From the perspective of healthcare policies,
such a mosaic of interrelations may not be entirely inop-
portune, since the interception of one disparity will
eventually affect other associated disparities. However, it
should be noted that speciﬁc patterns of high-volume
hospital utilisation may apply to different cancer sites.
Therefore, cancer-speciﬁc interventions aimed at redu-
cing such disparities may be required.
While the reasons for why disparities occur remain
unclear, what is deﬁnite is that barriers in accessing
higher quality of care have a direct impact on early
cancer detection and treatment. Under these circum-
stances, it has long been stated that “poverty is a carcino-
gen,”—a cancer-causing agent.31 For this reason,
effective policies and public health programmes have
been implemented to promote overall health awareness
among minorities and medically undeserved populations
in the USA.32
Table 3 Continued
Low
volume
High
volume p Value
$25 000–$34 999 24.9 24.0
$35 000–$44 999 26.8 23.1
≥$45 000 30.8 31.4
Prostatectomy
Race <0.001
Caucasian 56.5 62.4
African American 9.1 7.1
Hispanic 5.2 3.3
Others 3.6 3.7
Insurance status <0.001
Private 57.7 70.5
Medicaid 2.5 1.3
Medicare 33.9 25.2
Others 5.9 3.0
Median income <0.001
<$25 000 15.7 10.8
$25 000–$34 999 27.2 17.7
$35 000–$44 999 26.2 22.6
≥$45 000 28.1 45.8
*Percentages may not sum to 100 because unknown race and
ZIP code median income are not listed.
Table 4 Distribution of patients’ insurance status across
low-volume and high-volume hospitals according to race
groups, stratified according to each procedure
Low volume|high volume (%)
Caucasian
African
American Hispanic Others
Colectomy
Private 23|30 25|40 24|35 24|41
Medicaid 3|2 12|6 12|8 13|8
Medicare 70|67 53|50 52|52 54|48
Others 4|2 10|4 13|5 10|4
Cystectomy
Private 27|36 24|37 26|24 20|29
Medicaid 3|3 11|12 13|14 13|7
Medicare 67|57 60|43 49|45 58|59
Others 4|4 5|8 11|16 8|6
Oesophagectomy
Private 45|50 32|26 36|24 42|62
Medicaid 6|4 22|26 11|9 3|0
Medicare 46|44 37|49 41|55 52|25
Others 4|3 10|0 12|12 3|13
Hysterectomy
Private 45|54 34|41 41|49 48|62
Medicaid 3|3 15|8 17|16 15|5
Medicare 47|41 44|48 31|28 26|28
Others 6|3 8|3 12|7 11|5
Gastrectomy
Private 24|42 24|33 25|31 24|31
Medicaid 3|4 9|11 17|17 12|16
Medicare 69|50 60|48 47|42 52|45
Others 4|3 7|8 11|10 13|7
Lung resection
Private 31|38 29|39 23|42 29|38
Medicaid 4|3 11|11 14|11 14|9
Medicare 61|57 53|46 55|42 50|48
Others 4|3 7|4 8|5 8|5
Pancreatectomy
Private 36|43 35|40 27|40 30|40
Medicaid 3|3 12|12 19|17 17|3
Medicare 57|51 48|40 45|33 42|42
Others 4|3 6|7 10|11 11|15
Prostatectomy
Private 27|36 24|37 26|24 20|29
Medicaid 3|3 11|12 13|14 13|7
Medicare 67|57 60|43 49|45 58|59
Others 4|4 5|8 11|16 8|6
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Further efforts are needed to reduce disparities in
access to high-volume hospitals across the nation. Such
practice has been described as selective referral, which,
according to previous studies, may result in more
optimal postsurgical complications and mortality.9 33
While this remains a mere hypothesis, not practically
proven to be effective, its theoretical application has
been tested and recommended for some surgeries.33
However, if public health policymakers were to adopt
the implementation of selective referral, they may be
confronted with several challenges. For one, disparities
due to socioeconomic or racial factors have long been
recognised as a public health issue, not limited to
healthcare access. Inequities from work, wealth,
income and education levels, housing and overall
standard of living represent well-founded causes of dis-
parities not only for access to high-volume institutions,
but also to early detection and treatment. In addition,
discrimination also occurs, independent of insurance
status and income levels.29 In consequence, difﬁculties
may arise in the attempt to reduce disparities to utilisa-
tion of high-volume hospitals, if disparities occur at
another level. Speciﬁcally, it may be that high-volume
patients have previously undergone better preventive
healthcare—a timely treatment management and
other secondary care services relative to low-volume
patients, which gives them an advantage at the time of
surgery.
Table 5 Distribution of patients’ ZIP code income levels across low-volume and high-volume hospitals according to race
groups, stratified according to each procedure
Low volume|high volume (%)
Caucasian African American Hispanic Others
Colectomy
<$25 000 19|11 42|40 38|24 19|11
$25 000–$34 999 35|20 29|23 25|21 24|18
$35 000–$44 999 26|25 15|18 19|28 27|22
≥$45 000 18|42 11|17 15|24 26|47
Cystectomy
<$25 000 12|16 36|42 23|30 15|11
$25 000–$34 999 27|27 20|18 27|16 16|20
$35 000–$44 999 26|25 23|18 26|27 28|26
≥$45 000 33|30 18|19 18|17 36|41
Oesophagectomy
<$25 000 14|13 45|87 33|18 14|16
$25 000–$34 999 28|25 17|13 18|25 20|9
$35 000–$44 999 25|26 16|0 34|42 37|23
≥$45 000 32|33 22|0 15|12 29|36
Hysterectomy
<$25 000 12|8 29|35 35|32 9|9
$25 000–$34 999 31|19 29|21 23|19 22|18
$35 000–$44 999 27|27 23|18 22|22 20|20
≥$45 000 28|45 15|25 18|26 44|52
Gastrectomy
<$25 000 14|15 34|39 31|27 21|17
$25 000–$34 999 31|19 37|22 26|23 15|15
$35 000–$44 999 28|21 15|18 22|20 26|17
≥$45 000 25|44 11|19 19|29 36|49
Lung resection
<$25 000 14|14 34|41 29|21 15|12
$25 000–$34 999 27|21 28|22 23|14 21|15
$35 000–$44 999 27|23 20|19 21|21 24|24
≥$45 000 30|39 14|16 23|38 35|46
Pancreatectomy
<$25 000 12|16 38|49 31|30 8|11
$25 000–$34 999 25|25 23|23 26|20 23|20
$35 000–$44 999 27|23 24|17 19|21 24|20
≥$45 000 34|33 14|8 20|27 39|33
Prostatectomy
<$25 000 12|9 28|29 23|14 14|6
$25 000–$34 999 26|18 25|21 26|19 22|14
$35 000–$44 999 27|22 21|21 25|23 25|20
≥$45 000 32|49 22|27 21|29 34|54
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On the other hand, the process of regionalisation itself
may further exacerbate or maintain existing disparities.19
This may be due to patient-related health behaviour, such
as the mere lack of knowledge that higher procedure-
speciﬁc volume can improve outcomes, or to unavailable
means of transportation.9 Under these circumstances, the
conceptualisation and operationalisation of programmes
seeking to reduce disparities in utilisation of high-volume
complex surgical oncological procedures may not be
evident. However, failing to promptly address cancer dis-
parities, whether it is access to quality care, preventive
measures or early treatment and intervention, may ultim-
ately result in an irreconcilable divergence of the health-
care system among select segments of the US population.
Our study is not devoid of limitations. Primarily, owing
to the retrospective nature of the database, as well as the
limited information captured, it was not possible to
know why patients were not able to access high-volume
hospitals. For example, some physicians due to restric-
tions on insurance types are unable to accept Medicare
and Medicaid patients, which would ultimately represent
a different type of barrier, not necessarily related to
patient-directed discrimination, but merely for econom-
ical reasons. Other confounders that may restrict access
to care may also have been operational. In addition, the
NIS lacks clinical information, which prevented us from
adjusting for disease aggressiveness. Moreover, patient-
level income information was not available. Instead, we
relied on a county-derived estimation of patients’
income, which may be considered less reliable.
Importantly, the current ﬁndings may be strictly applic-
able to the healthcare system in the USA, which may not
Figure 1 Procedure-specific multivariable generalised linear regression models predicting the rate of high-volume hospital
utilisation focusing on the effect of race (A), insurance status (B) and ZIP code income (C) modulated as OR. Referent category
for all comparisons was Caucasian race, private insurance and income <$25 000, respectively. Error bars represent 95% CIs.
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be indicative of other regions/countries with differing
health-economic systems. Finally, the database used,
although large and generalisable, inherits conventional
limitations inherent of administrative cohorts, such as
errors in data collection, procedure classiﬁcation and
coding.34
CONCLUSIONS
Our study conﬁrms the existence of racial, payer and
socioeconomic disparities for high-volume hospital util-
isation, across several major complex surgical onco-
logical procedures within the USA. Such disparities may
vary depending on the type of cancer. Finally, causes of
cancer disparities that pertain to racial, insurance and/
or socioeconomic characteristics often reﬂect complex
interrelated associations.
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